Potential Change in Insulin Out-of-Pocket Spending Under Cost-Sharing Caps Among Pediatric Patients With Type 1 Diabetes
- PMID: 32716507
- PMCID: PMC7385670
- DOI: 10.1001/jamapediatrics.2020.1065
Potential Change in Insulin Out-of-Pocket Spending Under Cost-Sharing Caps Among Pediatric Patients With Type 1 Diabetes
Abstract
This cross-sectional study estimates the potential change in insulin out-of-pocket spending among privately insured children and young adults with type 1 diabetes if national caps were implemented.
Conflict of interest statement
Figures
References
-
- Biniek JF, Johnson W Spending on individuals with type 1 diabetes and the role of rapidly increasing insulin prices. Accessed January 7, 2020. https://www.healthcostinstitute.org/research/publications/entry/spending...
-
- Cigna and Express Scripts introduce patient assurance program to cap out of pocket costs at $25 per 30-day insulin prescription. News release. Cigna. April 3, 2019. Accessed January 7, 2020. https://www.cigna.com/newsroom/news-releases/2019/cigna-and-express-scri...
-
- Reduce Insulin Prices, HB19-1216, 72nd General Assembly (Col 2019). May 22, 2019. Accessed January 7, 2020. https://leg.colorado.gov/bills/hb19-1216
-
- IBM Watson Health Solution brief: IBM MarketScan Research Databases. Accessed February 8, 2020. https://www.ibm.com/downloads/cas/4QD5ADRL
-
- Board of Governors of the Federal Reserve System Report on the economic well-being of U.S. households in 2018. Accessed May 20, 2020. https://www.federalreserve.gov/publications/files/2018-report-economic-w...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
